glp 1 safety Researchers find GLP-1 medications safe to continue before surgery in patients with diabetes and obesity The Clinical Application of GLP-1RAs
Description
When to discuss a dose increase If you have been at your current dose for four or more weeks with minimal appetite suppression or weight change, a dose increase is usually the appropriate next step
L.ZhongW.ShuJ.Abu MuchA.LotanD.GrupperA.et al (2021)
The major inflammatory mediator interleukin-6 and obesity
Extended Data Figure 4 Walkthrough of peptide 5 interactions with GLP-1R StaR
[DOI] [PubMed] [Google Scholar] 61.Knezevich E, Crnic T, Kershaw S, Drincic A
